According to a new market report published by Lucintel, the future of the insulin delivery device market looks promising with opportunities in the patients/homecare and hospitals & clinic end use segments. The insulin delivery device market is expected to grow with a CAGR of 9% from 2019 to 2024. The major drivers for this market are growing geriatric population base, high adoption of sedentary lifestyle and growing awareness of diabetes treatment, technological advancements in insulin delivery devices, and rising awareness of advanced insulin delivery devices.
To download report brochure, please go to https://www.lucintel.com/insulin-delivery-device-market.aspx and click "report brochure" tab
In this market, various insulin devices are used to access an insulin dose, such as insulin pens, pumps, pen needles, and syringes. Insulin pens is the largest product segment of the insulin delivery device market.
North America will remain the largest region over the forecast period due to high prevalence of the condition in the US and the high adoption rate of advanced mechanisms.
Becton Dickinson and Company, Novo Nordisk A/S, Medtronic, Sanofi, ELI Lilly and Company, Ypsomed, Animas, Tandem Diabetes Care, Insulet, and Biocon are among the major manufacturers of insulin delivery devices.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the insulin delivery device market by product type, end user, and region. Lucintel has prepared a comprehensive research report titled "Insulin Delivery Device Market 2019-2024: Trends, Forecast, and Opportunity Analysis". The Lucintel report serves as a catalyst for growth strategies, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the insulin delivery device market by product type, end user, and region as follows:
By Product Type [$M shipment analysis for 2013 – 2024]:
Insulin Syringe
Insulin Pens
Insulin Pumps
Pen Needles
Other Devices
By End User [$M shipment analysis for 2013 – 2024]:
Patients/Homecare
Hospitals and Clinics
By Region [$M shipment analysis for 2013 – 2024]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Asia Pacific
ROW
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/insulin-delivery-device-market.aspx or helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.